Oct 30, 2025 / NTS GMT
Presentation
Oct 30, 2025 / NTS GMT
=====================
Corporate Participants
=====================
* Nobuko Kato
Astellas Pharma Inc - Chief Communications & IR Officer
* Naoki Okamura
Astellas Pharma Inc - President, Chief Executive Officer, Representative Director
* Tadaaki Taniguchi
Astellas Pharma Inc - Chief Research and Development Officer
* Claus Zieler
Astellas Pharma Inc - Chief Commercial & Medical Affairs Officer
* Atsushi Kitamura
Astellas Pharma Inc - Senior Managing Executive Officer, Chief Financial Officer
=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Global Markets Japan Inc - Analyst
* Seiji Wakao
JPMorgan Securities Japan Co Ltd - Analyst
* Akinori Ueda
Goldman Sachs Japan Co Ltd - Analyst
* Hiroyuki Matsubara
Nomura Securities International Inc - Analyst
* Fumiyoshi Sakai
UBS Securities Japan Co Ltd - Analyst
* Shinichiro Muraoka
Astellas Pharma Inc
(TSE:4503)
円
2,151
+3 (+0.14%)
Market Cap: 3.85 Tn
Enterprise Value: 4.13 Tn
PE Ratio: 13.26
PB Ratio: 2.11
GF Score: 82/100 Q2 2026 Astellas Pharma Inc Earnings Presentation Transcript
Oct 30, 2025 / NTS GMT
Release Date Price:
円1600
(+1.56%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot